Evvy: Funding, Investors & Team (Oct 2026)
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their mission is to close the gender health gap by discovering and leveraging overlooked biomarkers in the female body — starting with the vaginal microbiome.
Evvy has raised $59.0M across 3 funding rounds on record, the most recent a Series B of $40.0M announced in Sep 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evvy Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Evvy Funding Rounds
Evvy raised $5.0M in a Seed announced in Jul 2021.
2.2 years later, a Series A of $14.0M was announced in Sep 2023.
3 years later, a Series B of $40.0M was announced in Sep 2026.
Evvy Investors
18 investors are recorded in total; the 5 named above are those the record identifies.
Evvy Founders and Leadership Team
Contact details for the Evvy team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Evvy Funding Compared to Other Biotechnology Startups
Evvy's latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evvy in Biotechnology and Nyack
Companies Similar to Evvy
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Evvy Funding FAQs
What does Evvy do?
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their mission is to close the gender health gap by discovering and leveraging overlooked biomarkers in the female body — starting with the vaginal microbiome.
How much funding has Evvy raised?
Evvy has raised $59.0M across 3 rounds on record. The most recent is a Series B of $40.0M announced in Sep 2026.
When did Evvy last raise funding?
Evvy's most recent funding round on record is a Series B of $40.0M, announced in Sep 2026.
Who has invested in Evvy?
Investors on record for Evvy include BoxGroup, General Catalyst, Alumni Ventures, Catalio Capital Management, Rethink Impact. FundedIQ records 18 investors in total.
Who founded Evvy?
FundedIQ lists Laine Bruzek (Co-founder & Chief Marketing Officer) at Evvy.
Who is the CEO of Evvy?
Priyanka Jain is listed as CEO at Evvy.
Where is Evvy headquartered?
Evvy is based in Nyack, New York, United States.
How many employees does Evvy have?
Evvy is in the 1-10 employee band.
When was Evvy founded?
Evvy was founded in 2021.
How does Evvy's funding compare to other Biotechnology startups?
Evvy's latest round of $40.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Evvy Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evvy is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.